(Q44188489)

English

Efficacy and safety of fluticasone propionate 250 microg administered once daily in patients with persistent asthma treated with or without inhaled corticosteroids

scientific article published in October 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Efficacy and safety of fluticasone propionate 250 microg administered once daily in patients with persistent asthma treated with or without inhaled corticosteroids (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

fluticasone propionate

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

William E Berger

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Linda B Ford

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Todd Mahr

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Robert A Nathan

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Courtney Crim

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Lisa Edwards

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Donna S Wightman

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

William R Lincourt

8

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Kathleen Rickard

9

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Annals of Allergy, Asthma & Immunology

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

89

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

393-399

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Structure-activity relationships of topically active steroids: the selection of fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Binding kinetics of fluticasone propionate to the human glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of once- with twice-daily dosing of fluticasone propionate in mild and moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged airway activity and improved selectivity of budesonide possibly due to esterification.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A Comparison of the Effects of bid and qid Dosing on Compliance with Inhaled Flunisolide

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring compliance with inhaled medication in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Twice daily versus four times daily treatment with beclomethasone dipropionate in the control of mild childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A study on the clinical equivalence and patient preference of fluticasone propionate 250 microg twice daily via the Diskus/Accuhaler inhaler or the Diskhaler inhaler in adult asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of DiskusTMInhaler, a New Multidose Powder Inhaler, with DiskhalerTMInhaler for the Delivery of Salmeterol to Asthmatic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962041-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1081-1206(10)62041-8

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44188489&oldid=2127675038"